API

Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Deferasirox, marketed under the brand Refarmed Chemicals, is a cornerstone in the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia and sickle cell disease. This condition, if not properly managed, can have severe consequences for organ function. Deferasirox is available in oral tablet form, with strengths of 250 mg, 500 mg, and 1000 mg, allowing for flexibility and precision in dosing to meet individual patient needs. Crafted as an iron chelator, Deferasirox plays a crucial role in binding excess iron within the body and facilitating its excretion through urine. This targeted mechanism asserts its importance in maintaining a healthy balance of iron and preventing the potential toxicity associated with overload. Patients are advised to take Deferasirox with or without food, adhering to a dosing schedule that is tailored to their specific iron levels and bodily response, underscoring the need for a personalized approach to treatment. Regarding its physical properties, Deferasirox appears as a white to pale yellowish crystalline powder, primarily soluble in DMF (Dimethylformamide) and slightly soluble in methanol. These characteristics are essential for ensuring its effectiveness and stability as a pharmaceutical agent. It is imperative that patients undergo regular blood tests and health monitoring for optimum results and to prevent adverse effects such as gastrointestinal distress, skin reactions, and potential liver or renal impairment. Additionally, care must be taken in cases of known hypersensitivity to Deferasirox or pre-existing severe renal or liver conditions. Our documentation and certifications like Good Manufacturing Practice (GMP) and the Drug Master File (DMF) guarantee the highest levels of quality and compliance with industry standards. It is our priority to ensure that this crucial pharmaceutical material is of the utmost purity and efficacy, as reflected in our stringent quality control parameters including the presence of residual solvents and related substances, all documented for your assurance. Please note that while Deferasirox is a vital medication for many patients, it requires diligent medical supervision. Always consult healthcare professionals for specific medical advice and treatment instructions tailored to individual health profiles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]

Products still subject to third-party patent protection might be available solely for R&D purposes.

REFARMED CHEMICALS presents RamoseTron HCl, a high-purity pharmaceutical agent that serves as a critical component in mitigating the discomforting side effects associated with cancer treatments. Primarily utilized for its antiemetic properties, RamoseTron HCl is an effective serotonin (5-HT3) receptor antagonist, specifically formulated to prevent and treat nausea and vomiting induced by chemotherapy and radiation therapy. This product showcases our commitment to improving patient care during the rigorous journey of cancer treatment. RamoseTron HCl exhibits a remarkable ability to bind and block 5-HT3 receptors both in the gastrointestinal tract and the central nervous system—areas pivotal in cueing nausea and vomiting. By interrupting the signal transmission that triggers these adverse reactions, RamoseTron HCl lessens the severity and frequency of these symptoms, providing patients with much-needed relief. Tailored for adults and adolescents, RamoseTron HCl is administered orally or intravenously, dosed accordingly to align with the intensity of the emetogenic chemotherapy protocols. It ensures a rapid absorption with an extensive distribution throughout the body, assuring efficacy. The product is presented as a white to slightly yellowish-white crystalline powder, notable for its solubility in methanol, water, and ethanol—making it versatile for various pharmaceutical formulations. It meets rigorous quality standards, with certifications such as EU GMP, affirming its adherence to the highest production protocols. While offering substantial aid to cancer patients, healthcare providers must be attentive to possible contraindications and exercise caution in patients with specific medical conditions. Adverse effects, while generally manageable, must also be considered in the comprehensive patient care plan. REFARMED CHEMICALS' RamoseTron HCl is more than a medicine; it is a supportive ally for patients and healthcare providers in the fight against cancer and its challenging treatment side effects. Our product’s detailed specifications, as seen in the provided image, underscore our commitment to transparency and quality assurance.

Products still subject to third-party patent protection might be available solely for R&D purposes.